A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center researchers enables them to track the molecular evolution of cancers.
The Cornell Presidential Postdoctoral Fellowship Program, which attracts some of the world’s best young talent to Cornell, has chosen eight new fellows.
The student-run symposium recognizes research achievement and provides a venue for undergraduates to communicate their work in a scholarly environment.
While sifting through the bacterial genome of salmonella, Cornell food scientists discovered mcr-9, a stealthy jumping gene so diabolical that it resists one of the world’s few last-resort antibiotics.
A discovery by researchers at Weill Cornell Medicine has revealed that a molecule produced in stem-like cells may be therapeutic targets for obesity and related disorders.
The work of global oncologists has demonstrated value that academic medical leadership should consider when assessing these physicians for professional advancement.
A collaboration between five colleges and a provost’s office investment of $2 million has led to a major revitalization of Cornell’s capabilities in flow cytometry, a vital part of cell research.
Sugar glycation was shown to stiffen and alter the architecture of tissue and promote breast tumor cell movement, pointing to a possible mechanical link between diabetes and metastatic cancer.
Cornell’s Polson Institute for Global Development will host “Reducing Campus Food Waste: Innovations and Ideas,” a lecture and workshop May 2-3 on campus.